{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35519104", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "07", "Day": "27"}], "Language": ["eng"], "ELocationID": ["10.1039/d0ra05126h"], "Journal": {"ISSN": "2046-2069", "JournalIssue": {"Volume": "10", "Issue": "47", "PubDate": {"Year": "2020", "Month": "Jul", "Day": "27"}}, "Title": "RSC advances", "ISOAbbreviation": "RSC Adv"}, "ArticleTitle": "Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: identifying related therapeutic targets using network pharmacology and molecular docking analyses.", "Pagination": {"StartPage": "27961", "EndPage": "27983", "MedlinePgn": "27961-27983"}, "Abstract": {"AbstractText": ["Since the outbreak of Coronavirus disease (COVID-19) caused by SARS-CoV-2 in December 2019, there has been no vaccine or specific antiviral medication for treatment of the infection where supportive care and prevention of complications is the current management strategy. In this work, the potential use of medicinal plants and more than 16\u2009500 of their constituents was investigated within two suggested therapeutic strategies in the fight against SARS-CoV-2 including prevention of SARS-CoV-2 RNA synthesis and replication, through targeting vital proteins and enzymes as well as modulation of the host's immunity through production of virulence factors. Molecular docking studies on the viral enzymes 3Clpro, PLpro and RdRp suggested rocymosin B, verbascoside, rutin, caftaric acid, luteolin 7-rutinoside, fenugreekine and cyanidin 3-(6''-malonylglucoside) as promising molecules for further drug development. Meanwhile, the medicinal plants <i>Glycyrrhiza glabra</i>, <i>Hibiscus sabdariffa</i>, <i>Cichorium intybus</i>, <i>Chrysanthemum coronarium</i>, <i>Nigella sativa</i>, <i>Anastatica hierochuntica</i>, <i>Euphorbia species</i>, <i>Psidium guajava</i> and <i>Epilobium hirsutum</i> were enriched in compounds with the multi-targets PTGS2, IL2, IL1b, VCAM1 and TNF such as quercetin, ursolic acid, kaempferol, isorhamnetin, luteolin, glycerrhizin and apigenin. Enriched pathways of the molecular targets included cytokine-cytokine receptor interaction, TNF signaling pathway, NOD-like receptor signaling pathway, Toll-like receptor signaling pathway, NF-kappa B signaling pathway and JAK-STAT3 signaling pathway which are all closely related to inflammatory, innate and adaptive immune responses. The present study identified natural compounds targeting SARS-CoV-2 for further <i>in vitro</i> and <i>in vivo</i> studies and emphasizes the potential role of medicinal plants in the mitigation of SARS-CoV-2."], "CopyrightInformation": "This journal is \u00a9 The Royal Society of Chemistry."}, "AuthorList": [{"Identifier": ["0000-0003-0089-9629"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University Alexandria 21521 Egypt shawkyeman@yahoo.com eman.m.shawky@alexu.edu.eg +20 1005294669."}], "LastName": "Shawky", "ForeName": "Eman", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University Alexandria 21521 Egypt shawkyeman@yahoo.com eman.m.shawky@alexu.edu.eg +20 1005294669."}], "LastName": "Nada", "ForeName": "Ahmed A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University Alexandria 21521 Egypt shawkyeman@yahoo.com eman.m.shawky@alexu.edu.eg +20 1005294669."}], "LastName": "Ibrahim", "ForeName": "Reham S", "Initials": "RS"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "RSC Adv", "NlmUniqueID": "101581657", "ISSNLinking": "2046-2069"}, "CoiStatement": "None."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Woo P. C. Y. Lau S. K. P. Lam C. S. F. Lau C. C. Y. Tsang A. K. L. Lau J. H. N. Bai R. Teng J. L. L. Tsang C. C. C. Wang M. Zheng B.-J. Chan K.-H. Yuen K.-Y. Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavi. J. Virol. 2012;86:3995\u20134008. doi: 10.1128/JVI.06540-11.", "ArticleIdList": ["10.1128/JVI.06540-11", "PMC3302495", "22278237"]}, {"Citation": "\nWHO, Novel Coronavirus \u2013 China, https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/"}, {"Citation": "\nWHO, Pneumonia of unknown cause \u2013 China, https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/"}, {"Citation": "Zhu N. Zhang D. Wang W. Li X. Yang B. Song J. Zhao X. Huang B. Shi W. Lu R. Niu P. Zhan F. Ma X. Wang D. Xu W. Wu G. Gao G. F. Tan W. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727\u2013733. doi: 10.1056/NEJMoa2001017.", "ArticleIdList": ["10.1056/NEJMoa2001017", "PMC7092803", "31978945"]}, {"Citation": "Yang J. Zheng Y. Gou X. Pu K. Chen Z. Guo Q. Ji R. Wang H. Wang Y. Zhou Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int. J. Infect. Dis. 2020;94:91\u201395. doi: 10.1016/j.ijid.2020.03.017.", "ArticleIdList": ["10.1016/j.ijid.2020.03.017", "PMC7194638", "32173574"]}, {"Citation": "Lauer S. A. Grantz K. H. Bi Q. Jones F. K. Zheng Q. Meredith H. R. Azman A. S. Reich N. G. Lessler J. The incubation period of coronavirus disease 2019 (CoVID-19) from publicly reported confirmed cases: Estimation and application. Ann. Intern. Med. 2020;172:577\u2013582. doi: 10.7326/M20-0504.", "ArticleIdList": ["10.7326/M20-0504", "PMC7081172", "32150748"]}, {"Citation": "Wang W. Tang J. Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J. Med. Virol. 2020;92:441\u2013447. doi: 10.1002/jmv.25689.", "ArticleIdList": ["10.1002/jmv.25689", "PMC7167192", "31994742"]}, {"Citation": "Guan W. Ni Z. Hu Y. Liang W. Ou C. He J. Liu L. Shan H. Lei C. Hui D. S. C. Du B. Li L. Zeng G. Yuen K.-Y. Chen R. Tang C. Wang T. Chen P. Xiang J. Li S. Wang J. Liang Z. Peng Y. Wei L. Liu Y. Hu Y. Peng P. Wang J. Liu J. Chen Z. Li G. Zheng Z. Qiu S. Luo J. Ye C. Zhu S. Zhong N. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv. 2020;382:1708\u20131720.", "ArticleIdList": ["PMC7092819", "32109013"]}, {"Citation": "Wang D. Hu B. Hu C. Zhu F. Liu X. Zhang J. Wang B. Xiang H. Cheng Z. Xiong Y. Zhao Y. Li Y. Wang X. Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus\u2013Infected Pneumonia in Wuhan, China. J. Am. Med. Assoc. 2020;323:1061\u20131069. doi: 10.1001/jama.2020.1585.", "ArticleIdList": ["10.1001/jama.2020.1585", "PMC7042881", "32031570"]}, {"Citation": "Huang C. Wang Y. Li X. Ren L. Zhao J. Hu Y. Zhang L. Fan G. Xu J. Gu X. Cheng Z. Yu T. Xia J. Wei Y. Wu W. Xie X. Yin W. Li H. Liu M. Xiao Y. Gao H. Guo L. Xie J. Wang G. Jiang R. Gao Z. Jin Q. Wang J. Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506. doi: 10.1016/S0140-6736(20)30183-5.", "ArticleIdList": ["10.1016/S0140-6736(20)30183-5", "PMC7159299", "31986264"]}, {"Citation": "Mehta P. McAuley D. F. Brown M. Sanchez E. Tattersall R. S. Manson J. J. Lancet. 2020;395:1033\u20131034. doi: 10.1016/S0140-6736(20)30628-0.", "ArticleIdList": ["10.1016/S0140-6736(20)30628-0", "PMC7270045", "32192578"]}, {"Citation": "Diao B. Wang C. Tan Y. Chen X. Liu Y. Ning L. Chen L. Li M. Liu Y. Wang G. Yuan Z. Feng Z. Wu Y. Chen Y. Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19) medRxiv. 2020;11:827.", "ArticleIdList": ["PMC7205903", "32425950"]}, {"Citation": "Schett G. Sticherling M. Neurath M. F. COVID-19: risk for cytokine targeting in chronic inflammatory diseases? Nat. Rev. Immunol. 2020;20:271\u2013272. doi: 10.1038/s41577-020-0312-7.", "ArticleIdList": ["10.1038/s41577-020-0312-7", "PMC7186927", "32296135"]}, {"Citation": "Brune K. Frank J. Schwingshackl A. Finigan J. Sidhaye V. K. Pulmonary epithelial barrier function: some new players and mechanisms. Am. J. Physiol.: Lung Cell. Mol. Physiol. 2015;308:L731\u2013L745. doi: 10.1152/ajplung.00309.2014.", "ArticleIdList": ["10.1152/ajplung.00309.2014", "PMC4747906", "25637609"]}, {"Citation": "Leiva-Ju\u00e1rez M. M. Kolls J. K. Evans S. E. Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense. Mucosal Immunol. 2018;11:21\u201334. doi: 10.1038/mi.2017.71.", "ArticleIdList": ["10.1038/mi.2017.71", "PMC5738267", "28812547"]}, {"Citation": "Xu Z. Shi L. Wang Y. Zhang J. Huang L. Zhang C. Liu S. Zhao P. Liu H. Zhu L. Tai Y. Bai C. Gao T. Song J. Xia P. Dong J. Zhao J. Wang F.-S. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020;8:420\u2013422. doi: 10.1016/S2213-2600(20)30076-X.", "ArticleIdList": ["10.1016/S2213-2600(20)30076-X", "PMC7164771", "32085846"]}, {"Citation": "Wu C. Liu Y. Yang Y. Zhang P. Zhong W. Wang Y. Wang Q. Xu Y. Li M. Li X. Zheng M. Chen L. Li H. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B. 2020;10:766\u2013788. doi: 10.1016/j.apsb.2020.02.008.", "ArticleIdList": ["10.1016/j.apsb.2020.02.008", "PMC7102550", "32292689"]}, {"Citation": "Harcourt B. H. Jukneliene D. Kanjanahaluethai A. Bechill J. Severson K. M. Smith C. M. Rota P. A. Baker S. C. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J. Virol. 2004;78:13600\u201313612. doi: 10.1128/JVI.78.24.13600-13612.2004.", "ArticleIdList": ["10.1128/JVI.78.24.13600-13612.2004", "PMC533933", "15564471"]}, {"Citation": "Ziebuhr J. Snijder E. J. Gorbalenya A. E. Virus-encoded proteinases and proteolytic processing in the Nidovirales. J. Gen. Virol. 2000;81:853\u2013879. doi: 10.1099/0022-1317-81-4-853.", "ArticleIdList": ["10.1099/0022-1317-81-4-853", "10725411"]}, {"Citation": "Snijder E. J. Bredenbeek P. J. Dobbe J. C. Thiel V. Ziebuhr J. Poon L. L. M. Guan Y. Rozanov M. Spaan W. J. M. Gorbalenya A. E. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 2003;331:991\u20131004. doi: 10.1016/S0022-2836(03)00865-9.", "ArticleIdList": ["10.1016/S0022-2836(03)00865-9", "PMC7159028", "12927536"]}, {"Citation": "Marra M. A. Jones S. J. M. Astell C. R. Holt R. A. Brooks-Wilson A. Butterfield Y. S. N. Khattra J. Asano J. K. Barber S. A. Chan S. Y. Cloutier A. Coughlin S. M. Freeman D. Girn N. Griffith O. L. Leach S. R. Mayo M. McDonald H. Montgomery S. B. Pandoh P. K. Petrescu A. S. Robertson A. G. Schein J. E. Siddiqui A. Smailus D. E. Stott J. M. Yang G. S. Plummer F. Andonov A. Artsob H. Bastien N. Bernard K. Booth T. F. Bowness D. Czub M. Drebot M. Fernando L. Flick R. Garbutt M. Gray M. Grolla A. Jones S. Feldmann H. Meyers A. Kabani A. Li Y. Normand S. Stroher U. Tipples G. A. Tyler S. Vogrig R. Ward D. Watson B. Brunham R. C. Krajden M. Petric M. Skowronski D. M. Upton C. Roper R. L. The Genome Sequence of the SARS-Associated Coronavirus. Science. 2003;300:1399\u20131404. doi: 10.1126/science.1085953.", "ArticleIdList": ["10.1126/science.1085953", "12730501"]}, {"Citation": "Adedeji A. O. Marchand B. Te Velthuis A. J. W. Snijder E. J. Weiss S. Eoff R. L. Singh K. Sarafianos S. G. Mechanism of nucleic acid unwinding by SARS-CoV helicase. PLoS One. 2012;7:e36521. doi: 10.1371/journal.pone.0036521.", "ArticleIdList": ["10.1371/journal.pone.0036521", "PMC3352918", "22615777"]}, {"Citation": "Xia S. Liu M. Wang C. Xu W. Lan Q. Feng S. Qi F. Bao L. Du L. Liu S. Qin C. Sun F. Shi Z. Zhu Y. Jiang S. Lu L. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020;30:343\u2013355. doi: 10.1038/s41422-020-0305-x.", "ArticleIdList": ["10.1038/s41422-020-0305-x", "PMC7104723", "32231345"]}, {"Citation": "Chen Z. Nakamura T. Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS. Phytother. Res. 2004;18:592\u2013594. doi: 10.1002/ptr.1485.", "ArticleIdList": ["10.1002/ptr.1485", "15305324"]}, {"Citation": "Sahu K. K. Mishra A. K. Lal A. Comprehensive update on current outbreak of novel coronavirus infection (2019-nCoV) Ann. Transl. Med. 2020;8:393. doi: 10.21037/atm.2020.02.92.", "ArticleIdList": ["10.21037/atm.2020.02.92", "PMC7186600", "32355837"]}, {"Citation": "Zhang D., Zhang X., Peng B., Deng S., Wang Y., Yang L., Zhang K., Lin C. and Wu K., Molecular basis for treating COVID-19 with official Chinese herbal formula LCTE, 2020, 10.21203/rs.3.rs-20828/v1", "ArticleIdList": ["10.21203/rs.3.rs-20828/v1"]}, {"Citation": "Luo H. Tang Q.-L. Shang Y.-X. Liang S.-B. Yang M. Robinson N. Liu J.-P. Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs. Chin. J. Integr. Med. 2020;26:243\u2013250. doi: 10.1007/s11655-020-3192-6.", "ArticleIdList": ["10.1007/s11655-020-3192-6", "PMC7088641", "32065348"]}, {"Citation": "Dawood H. M. Ibrahim R. S. Shawky E. Hammoda H. M. Metwally A. M. Integrated in silico\u2013in vitro strategy for screening of some traditional Egyptian plants for human aromatase inhibitors. J. Ethnopharmacol. 2018;224:359\u2013372. doi: 10.1016/j.jep.2018.06.009.", "ArticleIdList": ["10.1016/j.jep.2018.06.009", "29909120"]}, {"Citation": "Ibrahim R. S. Mahrous R. S. R. Fathy H. M. Omar A. A. Abu EL-Khair R. M. Anticoagulant Activity Screening of an In-House Database of Natural Compounds for Discovering Novel Selective Factor Xa Inhibitors; A Combined In Silico and In Vitro Approach. Med. Chem. Res. 2020;29:707\u2013726. doi: 10.1007/s00044-020-02516-5.", "ArticleIdList": ["10.1007/s00044-020-02516-5"]}, {"Citation": "Anand K. Ziebuhr J. Wadhwani P. Mesters J. R. Hilgenfeld R. Coronavirus main proteinase (3CLpro) Structure: Basis for design of anti-SARS drugs. Science. 2003;300:1763\u20131767. doi: 10.1126/science.1085658.", "ArticleIdList": ["10.1126/science.1085658", "12746549"]}, {"Citation": "Pillaiyar T. Manickam M. Namasivayam V. Hayashi Y. Jung S. H. J. Med. Chem. 2016;59:6595\u20136628. doi: 10.1021/acs.jmedchem.5b01461.", "ArticleIdList": ["10.1021/acs.jmedchem.5b01461", "PMC7075650", "26878082"]}, {"Citation": "ul Qamar M. T. Alqahtani S. M. Alamri M. A. Chen L.-L. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J. Pharm. Anal. doi: 10.1016/j.jpha.2020.03.009.", "ArticleIdList": ["10.1016/j.jpha.2020.03.009", "PMC7156227", "32296570"]}, {"Citation": "Yuan L. Chen Z. Song S. Wang S. Tian C. Xing G. Chen X. Xiao Z. X. He F. Zhang L. P53 degradation by a coronavirus papain-like protease suppresses type I interferon signaling. J. Biol. Chem. 2015;290:3172\u20133182. doi: 10.1074/jbc.M114.619890.", "ArticleIdList": ["10.1074/jbc.M114.619890", "PMC4317044", "25505178"]}, {"Citation": "Gao Y. Yan L. Huang Y. Liu F. Zhao Y. Cao L. Wang T. Sun Q. Ming Z. Zhang L. Ge J. Zheng L. Zhang Y. Wang H. Zhu Y. Zhu C. Hu T. Hua T. Zhang B. Yang X. Li J. Yang H. Liu Z. Xu W. Guddat L. W. Wang Q. Lou Z. Rao Z. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020;368:779\u2013782. doi: 10.1126/science.abb7498.", "ArticleIdList": ["10.1126/science.abb7498", "PMC7164392", "32277040"]}, {"Citation": "Chu C. K. Gadthula S. Chen X. Choo H. Olgen S. Barnard D. L. Sidwell R. W. Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-CoV) Antiviral Chem. Chemother. 2006;17:285\u2013289. doi: 10.1177/095632020601700506.", "ArticleIdList": ["10.1177/095632020601700506", "17176633"]}, {"Citation": "Wang M. Cao R. Zhang L. Yang X. Liu J. Xu M. Shi Z. Hu Z. Zhong W. Xiao G. Cell Res. 2020;30:269\u2013271. doi: 10.1038/s41422-020-0282-0.", "ArticleIdList": ["10.1038/s41422-020-0282-0", "PMC7054408", "32020029"]}, {"Citation": "Wang Y. Zhang D. Du G. Du R. Zhao J. Jin Y. Fu S. Gao L. Cheng Z. Lu Q. Hu Y. Luo G. Wang K. Lu Y. Li H. Wang S. Ruan S. Yang C. Mei C. Wang Y. Ding D. Wu F. Tang X. Ye X. Ye Y. Liu B. Yang J. Yin W. Wang A. Fan G. Zhou F. Liu Z. Gu X. Xu J. Shang L. Zhang Y. Cao L. Guo T. Wan Y. Qin H. Jiang Y. Jaki T. Hayden F. G. Horby P. W. Cao B. Wang C. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395:1569\u20131578. doi: 10.1016/S0140-6736(20)31022-9.", "ArticleIdList": ["10.1016/S0140-6736(20)31022-9", "PMC7190303", "32423584"]}, {"Citation": "Vellingiri B. Jayaramayya K. Iyer M. Narayanasamy A. Govindasamy V. Giridharan B. Ganesan S. Venugopal A. Venkatesan D. Ganesan H. Rajagopalan K. Rahman P. K. S. M. Cho S.-G. Kumar N. S. Subramaniam M. D. COVID-19: A promising cure for the global panic. Sci. Total Environ. 2020:138277. doi: 10.1016/j.scitotenv.2020.138277.", "ArticleIdList": ["10.1016/j.scitotenv.2020.138277", "PMC7128376", "32278175"]}, {"Citation": "Vaninov N. In the eye of the COVID-19 cytokine storm. Nat. Rev. Immunol. 2020;20:277. doi: 10.1038/s41577-020-0305-6.", "ArticleIdList": ["10.1038/s41577-020-0305-6", "PMC7132547", "32249847"]}, {"Citation": "Wang W. He J. Lie P. Huang L. Wu S. Lin Y. Liu X. The definition and risks of Cytokine Release Syndrome-Like in 11 COVID-19-Infected Pneumonia critically ill patients: Disease Characteristics and Retrospective Analysis. medRxiv. 2020 doi: 10.1101/2020.02.26.20026989.", "ArticleIdList": ["10.1101/2020.02.26.20026989", "PMC7337810", "32601708"]}, {"Citation": "Conti P. Ronconi G. Caraffa A. Gallenga C. Ross R. Frydas I. Kritas S. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies. J. Biol. Regul. Homeostatic Agents. 2020;34:11\u201315.", "ArticleIdList": ["32171193"]}, {"Citation": "Smeitink J., Jiang X., Pecheritsyna S., Renkema H., Van Maanen R. and Beyrath J., Hypothesis: mPGES-1-derived Prostaglandin E2, a so far missing link in COVID-19 pathophysiology?, 2020, 10.20944/preprints202004.0180.v1", "ArticleIdList": ["10.20944/preprints202004.0180.v1"]}, {"Citation": "Pedersen S. F. Ho Y.-C. SARS-CoV-2: A Storm is Raging. J. Clin. Invest. 2020;130:2202\u20132205. doi: 10.1172/JCI137647.", "ArticleIdList": ["10.1172/JCI137647", "PMC7190904", "32217834"]}, {"Citation": "Zhang C. Wu Z. Li J.-W. Zhao H. Wang G.-Q. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int. J. Antimicrob. Agents. 2020:105954. doi: 10.1016/j.ijantimicag.2020.105954.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105954", "PMC7118634", "32234467"]}, {"Citation": "Farazuddin M. Mishra R. Jing Y. Srivastava V. Comstock A. T. Sajjan U. S. Quercetin prevents rhinovirus-induced progression of lung disease in mice with COPD phenotype. PLoS One. 2018;13:e0199612. doi: 10.1371/journal.pone.0199612.", "ArticleIdList": ["10.1371/journal.pone.0199612", "PMC6033397", "29975735"]}, {"Citation": "Wang L. Chen J. Wang B. Wu D. Li H. Lu H. Wu H. Chai Y. Protective effect of quercetin on lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammatory cell influx. Exp. Biol. Med. 2014;239:1653\u20131662. doi: 10.1177/1535370214537743.", "ArticleIdList": ["10.1177/1535370214537743", "24912504"]}, {"Citation": "Takashima K. Matsushima M. Hashimoto K. Nose H. Sato M. Hashimoto N. Hasegawa Y. Kawabe T. Protective effects of intratracheally administered quercetin on lipopolysaccharide-induced acute lung injury. Respir. Res. 2014;15:150. doi: 10.1186/s12931-014-0150-x.", "ArticleIdList": ["10.1186/s12931-014-0150-x", "PMC4276052", "25413579"]}, {"Citation": "Li C. Chen J. Yuan W. Zhang W. Chen H. Tan H. Preventive effect of ursolic acid derivative on particulate matter 2.5-induced chronic obstructive pulmonary disease involves suppression of lung inflammation. IUBMB Life. 2020;72:632\u2013640. doi: 10.1002/iub.2201.", "ArticleIdList": ["10.1002/iub.2201", "31840927"]}, {"Citation": "Zhao J. Zheng H. Sui Z. Jing F. Quan X. Zhao W. Liu G. Ursolic acid exhibits anti-inflammatory effects through blocking TLR4-MyD88 pathway mediated by autophagy. Cytokine. 2019;123:154726. doi: 10.1016/j.cyto.2019.05.013.", "ArticleIdList": ["10.1016/j.cyto.2019.05.013", "31302461"]}, {"Citation": "Zhou J.-X. Wink M. Evidence for Anti-Inflammatory Activity of Isoliquiritigenin, 18\u03b2 Glycyrrhetinic Acid, Ursolic Acid, and the Traditional Chinese Medicine Plants Glycyrrhiza glabra and Eriobotrya japonica, at the Molecular Level. Medicines. 2019;6:55. doi: 10.3390/medicines6020055.", "ArticleIdList": ["10.3390/medicines6020055", "PMC6630209", "31083310"]}, {"Citation": "Lee S. A. Lee S. H. Kim J. Y. Lee W. S. Effects of glycyrrhizin on lipopolysaccharide-induced acute lung injury in a mouse model. J. Thorac. Dis. 2019;11:1287\u20131302. doi: 10.21037/jtd.2019.04.14.", "ArticleIdList": ["10.21037/jtd.2019.04.14", "PMC6531684", "31179071"]}, {"Citation": "Shi Y. Wang Y. Shao C. Huang J. Gan J. Huang X. Bucci E. Piacentini M. Ippolito G. Melino G. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27:1451\u20131454. doi: 10.1038/s41418-020-0530-3.", "ArticleIdList": ["10.1038/s41418-020-0530-3", "PMC7091918", "32205856"]}, {"Citation": "Wu D. Yang X. O. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib. J. Microbiol., Immunol. Infect. 2020;53(3):368\u2013370. doi: 10.1016/j.jmii.2020.03.005.", "ArticleIdList": ["10.1016/j.jmii.2020.03.005", "PMC7156211", "32205092"]}, {"Citation": "McGonagle D. Sharif K. O'Regan A. Bridgewood C. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun. Rev. 2020:102537. doi: 10.1016/j.autrev.2020.102537.", "ArticleIdList": ["10.1016/j.autrev.2020.102537", "PMC7195002", "32251717"]}, {"Citation": "Hanley B. Lucas S. B. Youd E. Swift B. Osborn M. Autopsy in suspected COVID-19 cases. J. Clin. Pathol. 2020;73(5):239\u2013242. doi: 10.1136/jclinpath-2020-206522.", "ArticleIdList": ["10.1136/jclinpath-2020-206522", "32198191"]}, {"Citation": "McGonagle D. Sharif K. O'Regan A. Bridgewood C. Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome. Autoimmun. Rev. 2020:102537. doi: 10.1016/j.autrev.2020.102537.", "ArticleIdList": ["10.1016/j.autrev.2020.102537", "PMC7195002", "32251717"]}, {"Citation": "Li C. Eom T. Jeong Y. Glycyrrhiza glabra L. extract inhibits LPS-induced inflammation in RAW macrophages. J. Nutr. Sci. Vitaminol. 2015;61:375\u2013381. doi: 10.3177/jnsv.61.375.", "ArticleIdList": ["10.3177/jnsv.61.375", "26639845"]}, {"Citation": "Samareh Fekri M. Poursalehi H. R. Sharififar F. Mandegary A. Rostamzadeh F. Mahmoodi R. The effects of methanolic extract of Glycyrrhiza glabra on the prevention and treatment of bleomycin-induced pulmonary fibrosis in rat: experimental study. Drug Chem. Toxicol. doi: 10.1080/01480545.2019.1606232.", "ArticleIdList": ["10.1080/01480545.2019.1606232", "31072167"]}, {"Citation": "Frattaruolo L. Carullo G. Brindisi M. Mazzotta S. Bellissimo L. Rago V. Curcio R. Dolce V. Aiello F. Cappello A. R. Antioxidant and anti-inflammatory activities of flavanones from Glycyrrhiza glabra L. (licorice) leaf phytocomplexes: Identification of licoflavanone as a modulator of NF-kB/MAPK pathway. Antioxidants. 2019;8:186. doi: 10.3390/antiox8060186.", "ArticleIdList": ["10.3390/antiox8060186", "PMC6616548", "31226797"]}, {"Citation": "Garbi M. I. Mohammed S. F. Magzoub A. A. Hassabelrasoul R. M. Saleh M. S. Badri A. M. Ibrahim I. T. Elshikh A. A. Kabbashi A. S. Mohamed C. Garbi I. In vitro anti-inflammatory properties of methanolic extract of Hibiscus sabdariffa flowers. Int. J. Home Sci. 2017;3:234\u2013237."}, {"Citation": "Sogo T. Terahara N. Hisanaga A. Kumamoto T. Yamashiro T. Wu S. Sakao K. Hou D. X. Anti-inflammatory activity and molecular mechanism of delphinidin 3-sambubioside, a Hibiscus anthocyanin. BioFactors. 2015;41:58\u201365. doi: 10.1002/biof.1201.", "ArticleIdList": ["10.1002/biof.1201", "25728636"]}, {"Citation": "Rizvi W. Fayazuddin M. Shariq S. Singh O. Moin S. Akhtar K. Kumar A. Anti-inflammatory activity of roots of Cichorium intybus due to its inhibitory effect on various cytokines and antioxidant activity. Anc. Sci. Life. 2014;34:44. doi: 10.4103/0257-7941.150780.", "ArticleIdList": ["10.4103/0257-7941.150780", "PMC4342649", "25737610"]}, {"Citation": "Rezagholizadeh L. Pourfarjam Y. Nowrouzi A. Nakhjavani M. Meysamie A. Ziamajidi N. Nowrouzi P. S. Effect of Cichorium intybus L. on the expression of hepatic NF-\u03baB and IKK\u03b2 and serum TNF-a\u03b1 in STZ- and STZ+ niacinamide-induced diabetes in rats. Diabetol. Metab. Syndr. 2016;8:11. doi: 10.1186/s13098-016-0128-6.", "ArticleIdList": ["10.1186/s13098-016-0128-6", "PMC4752748", "26877773"]}, {"Citation": "Strzelecka M. Bzowska M. Kozie\u0142 J. Szuba B. Dubiel O. Rivera Nunez D. Heinrich M. Bereta J. J. Physiol. Pharmacol. 2005;56:139\u2013156.", "ArticleIdList": ["15800391"]}, {"Citation": "Bordoni L. Fedeli D. Nasuti C. Maggi F. Papa F. Wabitsch M. De Caterina R. Gabbianelli R. Antioxidant and anti-inflammatory properties of nigella sativa oil in human pre-adipocytes. Antioxidants. 2019;8:51. doi: 10.3390/antiox8020051.", "ArticleIdList": ["10.3390/antiox8020051", "PMC6406245", "30823525"]}, {"Citation": "Majdalawieh A. F. Fayyad M. W. Int. Immunopharmacol. 2015;28:295\u2013304. doi: 10.1016/j.intimp.2015.06.023.", "ArticleIdList": ["10.1016/j.intimp.2015.06.023", "26117430"]}, {"Citation": "Fiore C. Eisenhut M. Krausse R. Ragazzi E. Pellati D. Armanini D. Bielenberg J. Phyther Res. 2008;22:141\u2013148. doi: 10.1002/ptr.2295.", "ArticleIdList": ["10.1002/ptr.2295", "PMC7167979", "17886224"]}, {"Citation": "Shen H. Yamashita A. Nakakoshi M. Yokoe H. Sudo M. Kasai H. Tanaka T. Fujimoto Y. Ikeda M. Kato N. Sakamoto N. Shindo H. Maekawa S. Enomoto N. Tsubuki M. Moriishi K. Inhibitory effects of caffeic acid phenethyl ester derivatives on replication of hepatitis C virus. PLoS One. 2013;8:e82299. doi: 10.1371/journal.pone.0082299.", "ArticleIdList": ["10.1371/journal.pone.0082299", "PMC3866116", "24358168"]}, {"Citation": "Xie Y. Huang B. Yu K. Xu W. Further discovery of caffeic acid derivatives as novel influenza neuraminidase inhibitors. Bioorg. Med. Chem. 2013;21:7715\u20137723. doi: 10.1016/j.bmc.2013.10.020.", "ArticleIdList": ["10.1016/j.bmc.2013.10.020", "24262883"]}, {"Citation": "Wu Y.-H. Zhang B.-Y. Qiu L.-P. Guan R.-F. Ye Z.-H. Yu X.-P. Structure Properties and Mechanisms of Action of Naturally Originated Phenolic Acids and Their Derivatives against Human Viral Infections. Curr. Med. Chem. 2017;24:3995\u20134008.", "ArticleIdList": ["28814240"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "6", "Day": "10"}, {"Year": "2020", "Month": "7", "Day": "17"}, {"Year": "2022", "Month": "5", "Day": "6", "Hour": "6", "Minute": "2"}, {"Year": "2020", "Month": "7", "Day": "27", "Hour": "0", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "27", "Hour": "0", "Minute": "1"}, {"Year": "2020", "Month": "7", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["35519104", "PMC9055652", "10.1039/d0ra05126h", "d0ra05126h"]}}], "PubmedBookArticle": []}